Invuity® Announces Launch Of Eikon™ LT Illuminated Retractor System At American College Of Surgeons 2015 Clinical Congress

CHICAGO, Oct. 5, 2015 /PRNewswire/ -- Invuity, Inc. (NASDAQ:IVTY), an advanced medical technology company, today announced the introduction of its Eikon™ LT illuminated retractor system, expanding the company's portfolio of devices that improve intra-cavity illumination and visualization. Eikon LT integrates Invuity's Intelligent Photonics™ technology to enable minimally invasive and minimal access open surgeries, including breast oncology and reconstruction, thyroid oncology and general surgery. As showcased at the American College of Surgeons (ACS) Clinical Congress in Chicago, the Eikon LT system expands the existing Eikon platform while integrating design enhancements that further enable surgical precision, efficiency and safety.

The next-generation Eikon LT platform addresses key safety priorities for hospitals and health systems. As the numbers of minimally invasive surgeries rise, electrosurgical devices have shown to be potential sources of thermal burns and operating room fires. In response to hospital initiatives focused on ensuring safety during minimally invasive surgeries, Invuity engineered a proprietary high performance material. This reinforced polymer material is 100 percent non-conductive, eliminating the risks related to overheating, and the potential for burns due to arcing from electrosurgical devices. Eikon LT's non-conductive material, coupled with its proprietary thermally cool illumination, virtually eliminates the known thermal hazards associated with traditional electrosurgical devices and fiber optics.

Forty percent lighter than traditional retractors, Eikon LT also helps reduce fatigue and improves efficiency for surgeons operating through deep, dark cavities while using smaller incisions. Additional enhancements to the blade and tip further enable surgeons to optimize clinical and cosmetic outcomes in minimally invasive procedures – including Hidden Scar™ Breast Cancer Surgery. The device's smooth edges reduce tissue trauma and allow for easy maneuverability, while flexibility in the blade puts less tension, stress and trauma on the breast flap to maintain flap viability and integrity.

"The Eikon LT's lightweight design and flexible blade enable me to operate more efficiently, and improve breast flap viability without the worry of burn injury," said Sunny Mitchell, MD, Associate Chairperson of Surgery and Director of Women's Health Services at Coney Island Hospital. "This type of innovation enables enhancements in surgical technique that improve patient safety and the overall patient experience."

Eikon LT accommodates multiple hand positions for various hand sizes, and offers an improved ergonomic design that reduces surgeon fatigue. Grooves in the handle and thumb slots provide for a comfortable grip that also prevents hand slippage, further improving the surgeon's precision. To accommodate physician preferences and varying patient anatomies, the Eikon LT is available in multiple sizes, with eight retractors in the system ranging from 40mm to 175mm.

"We're continually looking for innovative ways to address real-world needs for healthcare providers and to drive clinical improvements in minimal access surgery," said Paul Davison, Vice President of Research and Development at Invuity. "One way to do that is to provide thermally cool illumination and eliminate the potential for patient burns. We developed a proprietary reinforced polymer material for Eikon LT that is 100 percent non-conductive, improving safety in the operating room and further reducing the risk of burns caused by electrosurgical device arcing."

The Eikon LT illuminated retractor system is commercially available beginning today. For more information, please visit booth #1235 at ACS 2015 or www.invuity.com/products/retractors.

About Invuity®
Invuity, Inc. is a medical technology company focused on developing and marketing advanced photonics devices to improve the ability of surgeons to illuminate and visualize the surgical cavity during minimally invasive and minimal access open surgery. The company's patented Intelligent Photonics™ technology enables enhanced surgical precision, efficiency and safety by providing superior visualization. Clinical applications include breast and thyroid oncology, plastic reconstructive, spine, orthopedic, cardiothoracic and general surgery among others. Invuity is headquartered in San Francisco, CA. For more information, visit www.invuity.com.

Forward-Looking Statements
This announcement contains forward-looking statements that involve risks and uncertainties, including statements regarding market opportunities and potential results from future new initiatives. Actual results could differ materially from those projected in the forward-looking statements as a result of certain risk factors, including, but not limited to: fluctuations in demand or failure to gain market acceptance for the Company's devices; the Company's ability to demonstrate to and gain approval from hospitals to use the Company's devices; the highly competitive business environment for surgical medical devices; the Company's ability to sell its devices at prices that support its current business strategies; difficulty forecasting future financial performance; protection of the Company's intellectual property; and compliance with necessary regulatory clearances or approvals. The Company undertakes no obligation to update the forward-looking information in this release. More information about potential factors that could affect the Company's business and financial results is included in its filings with the Securities and Exchange Commission, including, without limitation, under the captions: "Management's Discussion and Analysis of Financial Condition and Results of Operations," and "Risk Factors," which are on file with the Securities and Exchange Commission.

SOURCE Invuity, Inc.

Related Links

http://www.invuity.com